Shenglin Ma

Title: Innovations of Shenglin Ma

Introduction

Shenglin Ma is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of immunology, particularly through his innovative work on immunotoxin fusion proteins. With a total of 4 patents to his name, Ma's inventions have the potential to impact therapeutic approaches in medicine.

Latest Patents

One of Shenglin Ma's latest patents is focused on immunotoxin fusion proteins and means for expression thereof. This invention describes novel recombinant DT-based immunotoxins, specifically targeting anti-T cell immunotoxin fusion proteins. The patent also details immunotoxins that can be expressed in various cell types, including bacterial, yeast, or mammalian cells. The invention provides essential means for the expression of the immunotoxin fusion protein, ensuring that the technical disclosure is clear and accessible for further research and application.

Career Highlights

Throughout his career, Shenglin Ma has worked with prestigious organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and Novartis AG. His experience in these institutions has allowed him to develop and refine his innovative ideas in the field of immunology.

Collaborations

Shenglin Ma has collaborated with notable colleagues such as David M. Neville and Jerry Todd Thompson. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Shenglin Ma's work in immunotoxin fusion proteins showcases his innovative spirit and dedication to advancing medical science. His contributions are significant and hold promise for future therapeutic applications.